Depatuxizumab mafodotin Completed Phase 1 Trials for Glioblastoma Multiforme (GBM) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01800695Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme